NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 318 filers reported holding NOVOCURE LTD in Q2 2022. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,268,421 | +79.7% | 37,719 | +126.9% | 0.09% | +91.8% |
| Q3 2022 | $1,262,000 | -66.9% | 16,622 | -63.9% | 0.05% | -70.1% |
| Q1 2022 | $3,811,000 | +456.4% | 46,000 | +404.2% | 0.16% | +281.4% |
| Q4 2021 | $685,000 | -78.2% | 9,124 | -66.2% | 0.04% | -81.1% |
| Q3 2021 | $3,137,000 | +151.6% | 27,000 | +186.1% | 0.23% | +95.7% |
| Q1 2021 | $1,247,000 | +37.0% | 9,436 | +79.4% | 0.12% | -25.2% |
| Q4 2020 | $910,000 | +135.8% | 5,260 | +51.5% | 0.16% | +98.7% |
| Q3 2020 | $386,000 | – | 3,472 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nordwand Advisors, LLC | 1,515,000 | $111,125,249 | 13.86% |
| Invus Financial Advisors, LLC | 350,884 | $25,737,341 | 13.70% |
| HARTLINE INVESTMENT CORP/ | 304,482 | $22,333,755 | 5.08% |
| GREAT POINT PARTNERS LLC | 241,000 | $17,677,350 | 3.46% |
| Tri Locum Partners LP | 72,400 | $5,311,000 | 2.15% |
| Taylor Frigon Capital Management LLC | 42,061 | $3,085,174 | 1.75% |
| HighVista Strategies LLC | 28,007 | $2,054,313 | 1.22% |
| HAP Trading, LLC | 124,500 | $10,294 | 1.05% |
| Private Harbour Investment Management & Counsel, LLC | 12,285 | $901,105 | 0.99% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 32,000 | $2,344,000 | 0.72% |